Factors and strategies for improving buccal absorption of peptides.
about
Emerging Trends in Noninvasive Insulin DeliverySuccessful identification of novel agents to control infectious diseases from screening mixture-based peptide combinatorial libraries in complex cell-based bioassays.Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosanThe quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro.Buccal delivery systems.In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer.A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methodsBuccal drug delivery.Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Delivery of optical contrast agents using Triton-X100, part 2: enhanced mucosal permeation for the detection of cancer biomarkers.Critical evaluation of permeation enhancers for oral mucosal drug delivery.Chemical permeation enhancers for transbuccal drug delivery.Oral insulin and buccal insulin: a critical reappraisal.Mucoadhesive drug delivery system: An overview.Strategies for enhanced peptide and protein delivery.Novel strategies for the buccal delivery of macromolecules.Enhancing the buccal mucosal delivery of peptide and protein therapeutics.Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primerIntestinal transepithelial permeability of oxytocin into the blood is dependent on the receptor for advanced glycation end products in mice.Peptidomimetic therapeutics: scientific approaches and opportunities.Oromucosal multilayer films for tailor-made, controlled drug delivery.Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers.Transbuccal delivery of 5-aza-2 -deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation.Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine.The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.Peptide washout and permeability from glyceryl monooleate buccal delivery systems.Biopolymeric mucoadhesive bilayer patch of pravastatin sodium for buccal delivery and treatment of patients with atherosclerosis.Effect of pH on in vitro permeation of ondansetron hydrochloride across porcine buccal mucosa.Effect of matrix composition, sphere size and hormone concentration on diffusion coefficient of insulin for controlled gastrointestinal delivery for diabetes treatment.Potential mucoadhesive dosage form of lidocaine hydrochloride: II. In vitro and in vivo evaluation.Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue.Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules.Buccal Drug Delivery SystemsPolymers and Biopolymers in Pharmaceutical Technology
P2860
Q27024335-4EF6C16C-A978-4FBD-8745-58C83FDA925AQ30937880-D24BDEB6-147C-427C-ACE6-561B5B9930DBQ33731655-BFFDA264-B526-4D2D-A23E-D6BE2E3944B3Q34467527-8333D709-4CF7-4B1C-B38D-ADEECCAFA29FQ35564695-05446ABB-D368-44EC-B56C-97F22A296D15Q35821884-58653059-82B2-42F7-88BA-E46D65A06365Q36215627-94E9F94B-FD50-4473-B8BD-0738B7B8C531Q36316789-4866F113-292C-4172-974F-618FBE330EB3Q36640081-68C016C8-D953-40EE-A312-BB05969479C3Q37353336-63FFC644-9152-4A12-9C8D-793F91B0F3F2Q37575468-BB74175E-7F77-425C-A03A-CBCEFCFC70B1Q37657520-C3CF6B39-5182-4640-9389-F3B1778DA061Q37689833-16AD4AB4-99CA-43D3-B3CA-403CC88D454DQ37976080-79D81564-03C6-4E51-9688-CFB3252F6978Q38104408-A94D3FC3-A849-4FCA-AFEC-F3ABC9398C04Q38194614-0B2EA0CF-1176-4344-B14D-EE1B0D0740B4Q38244323-CB8166DD-C44B-4A1E-A677-BEF136793593Q38268308-C79EBE1C-2B29-47F6-8A08-2F69E3E2F0B6Q38628151-55738619-9968-4C66-94B8-3732F41E2F15Q39011193-95D68F85-6164-4B7C-A851-15BEF3483734Q39044358-5505E56A-83E3-424C-A90B-E3DACDCB9614Q39434951-A1A5AAC7-A970-4430-AD04-9848C4E8DBADQ41966277-DE47F216-EE9B-45D1-994B-F6DD1C570D7AQ42705620-F69EC773-2A00-479F-8C22-FFC1F73F0C2DQ43996955-45489A1A-E882-4A1A-93FD-0EFA2CD4C9B7Q44231992-D6898EF2-89F9-41B0-9563-76AB5E979CC2Q46299663-5902E176-406D-4E72-AE80-46849E7C82A5Q46519457-86EAF85D-4E3E-4AB6-96D3-618B5AFE0618Q47175658-AE7FCC58-A64B-47FB-B069-82B8E39A7B08Q48595300-F46018D8-3A22-4234-A8BD-40F702E06789Q51137694-D413A2C3-188D-4D5A-81C2-F9367211D820Q53624619-6617668E-A040-4A80-9C9B-14FFE85CBE5AQ57340405-EAF3D219-F2EF-4FFC-A186-321B2748EE18Q57340433-DB06104C-256F-43CB-A8CE-BCAE59B2BFF9
P2860
Factors and strategies for improving buccal absorption of peptides.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Factors and strategies for improving buccal absorption of peptides.
@ast
Factors and strategies for improving buccal absorption of peptides.
@en
Factors and strategies for improving buccal absorption of peptides.
@nl
type
label
Factors and strategies for improving buccal absorption of peptides.
@ast
Factors and strategies for improving buccal absorption of peptides.
@en
Factors and strategies for improving buccal absorption of peptides.
@nl
prefLabel
Factors and strategies for improving buccal absorption of peptides.
@ast
Factors and strategies for improving buccal absorption of peptides.
@en
Factors and strategies for improving buccal absorption of peptides.
@nl
P2093
P1476
Factors and strategies for improving buccal absorption of peptides
@en
P2093
P304
P356
10.1016/S0939-6411(00)00144-2
P407
P577
2001-03-01T00:00:00Z